Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Pneumothorax II: Pathophysiology

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...

Chronic Obstructive Pulmonary Disease II: Emphysema

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.

Pneumothorax-II

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:

Atelectasis II: Pathophysiology

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Exploring the Role of Hypusine Signaling in Vascular Smooth Muscle Cells for Mitigating Restenosis in Coronary Artery Disease.

Arteriosclerosis, thrombosis, and vascular biology·2026

Same author

Impaired Lung BCAA Metabolism Promotes Ferroptosis and Resultant Pulmonary Arterial Hypertension-Associated Hepatopathy.

JACC. Basic to translational science·2026

Same author

Pulmonary arterial hypertension induces a metabolic and inflammatory hepatopathy.

The Journal of clinical investigation·2026

Same author

Correction to: Breast Cancer Reveals Latent <i>BMPR2</i>-Related Susceptibility to Pulmonary Hypertension.

Circulation·2026

Same author

Pulmonary Arterial Hypertension Induces a Metabolic and Inflammatory Hepatopathy.

bioRxiv : the preprint server for biology·2026

Same author

Critical Contribution of Cardiac Myofibroblasts in Right Ventricular Failure and the Role of UCP2 SNPs in the Predisposition to RV Decompensation in Pulmonary Arterial Hypertension.

Circulation·2026

Search research articles

Related Experiment Video

Updated: May 26, 2026

Mouse Pneumonectomy Model of Compensatory Lung Growth

Mouse Pneumonectomy Model of Compensatory Lung Growth

Published on: December 17, 2014

Long-term physiological consequences of pneumonectomy.

Jean Deslauriers¹, Paula Ugalde, Santiago Miro

¹Department of Thoracic Surgery, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, Quebec, Canada. jean.deslauriers@chg.ulaval.ca

Seminars in Thoracic and Cardiovascular Surgery

|December 17, 2011

Summary

Patients can adapt to living with one lung after pneumonectomy, achieving near-normal lives. Contrary to past beliefs, residual lung hyperinflation is beneficial for lung function post-surgery.

More Related Videos

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Published on: January 23, 2026

Related Experiment Videos

Last Updated: May 26, 2026

Mouse Pneumonectomy Model of Compensatory Lung Growth

Mouse Pneumonectomy Model of Compensatory Lung Growth

Published on: December 17, 2014

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Published on: January 23, 2026

Area of Science:

Pulmonary Medicine
Thoracic Surgery
Physiology

Background:

Historical pneumonectomy studies often involved benign diseases or small, varied patient groups.
This led to persistent surgical myths regarding patient outcomes and physiological changes.
Such myths include the desirability of phrenic nerve interruption and negative impacts of lung hyperinflation.

Purpose of the Study:

To investigate the long-term physiological consequences of pneumonectomy for lung cancer.
To challenge and clarify persistent surgical myths about post-pneumonectomy patient status.
To evaluate patient functional status and quality of life years after lung cancer surgery.

Main Methods:

A longitudinal study of 100 patients who underwent pneumonectomy for lung cancer.
Patients were evaluated at least 5 years post-surgery, with a mean follow-up of 9.1 years.
Analysis focused on respiratory function, exercise tolerance, and overall quality of life.

Main Results:

Most patients successfully adapt to living with a single lung, maintaining a near-normal life.
Diaphragmatic paralysis causes significant respiratory alterations.
Residual lung hyperinflation was found to be beneficial, not detrimental, to lung function.

Conclusions:

Pneumonectomy patients can achieve good long-term functional status and quality of life.
Surgical myths regarding lung hyperinflation and patient outcomes are challenged by these findings.
The study highlights the body's adaptive capacity after major lung resection for cancer.